drugset / Trial / NCT02254109
Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Rising of BEA 2180 BR in Japanese Healthy Male Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
Study to evaluate safety, tolerability, and pharmacokinetics of BEA 2180 BR in Japanese healthy volunteers
Timeline
- Start
- 2008-04
- Primary completion
- 2008-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BEA 2180 BR | Unknown | 50 ug | — |
| Subject | BEA 2180 BR | Unknown | 100 ug | — |
| Subject | BEA 2180 BR | Unknown | 200 ug | — |
Indications
No indication recorded.